TheraRadar

Pharma Intelligence, Simplified

Landscape → CNS

Anxiety

259 clinical trials

90 active
/
259 total (since 2015)
9
Phase 1 Active
42 total
47
Phase 2 Active
135 total
23
Phase 3 Active
51 total
17
Phase 4 Active
56 total

Top Sponsors (Industry)

Sorted by active Active Done Failed
VistaGen Therapeutics, Inc. 3 1 2
Definium Therapeutics US, Inc. 2 1 0
Intra-Cellular Therapies, Inc. 2 0 0
Beijing Union Pharmaceutical Factory Ltd 2 0 0
AbbVie 1 3 1
Engrail Therapeutics INC 1 2 0
Vanda Pharmaceuticals 1 1 0
Otsuka Pharmaceutical Development & Commercialization, Inc. 1 1 0
Valenta Pharm JSC 1 1 0
Ono Pharmaceutical Co. Ltd 1 0 0
Newleos Therapeutics, Inc. 1 0 0
RDC Clinical Pty Ltd 1 0 0
Cybin IRL Limited 1 0 0
Nyree Penn 1 0 0
Sichuan Jishengtang Pharmaceutical Co., Ltd. 1 0 0
NCT07221578 RECRUITING
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder
Vanda Pharmaceuticals n=500
NCT06741228 RECRUITING
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
Definium Therapeutics US, Inc. n=200
NCT06809595 RECRUITING
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
Definium Therapeutics US, Inc. n=250
NCT06615557 RECRUITING
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
VistaGen Therapeutics, Inc. n=236
NCT07336095 NOT YET RECRUITING
Melatonin vs Midazolam in Children Undergoing Tonsillectomy
Ain Shams University n=195
NCT05552053 RECRUITING
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
Cedars-Sinai Medical Center n=150
NCT06358651 ACTIVE NOT RECRUITING
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)
VistaGen Therapeutics, Inc. n=238
NCT05474846 RECRUITING
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
M.D. Anderson Cancer Center n=188
NCT05625360 RECRUITING
REmotely-delivered Supportive Programs for Improving Surgical Pain and disTrEss
Wake Forest University Health Sciences n=160
NCT06273527 RECRUITING
Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)
University of California, San Diego n=128
NCT06973577 RECRUITING
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
Otsuka Pharmaceutical Development & Commercialization, Inc. n=308
NCT07123467 NOT YET RECRUITING
Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder
Wayne State University n=90
NCT07138391 NOT YET RECRUITING
Chamomile Gummies and Pediatric Dental Anxiety
Ain Shams University n=78
NCT04760275 ACTIVE NOT RECRUITING
Fluoxetine vs CBT in Childhood Anxiety Disorders
Children's Hospital Los Angeles n=316
NCT04598230 ACTIVE NOT RECRUITING
Partners in Caring for Anxious Youth
Ann & Robert H Lurie Children's Hospital of Chicago n=468
NCT06752759 RECRUITING
Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting
Theresa Jacob, PhD, MPH n=40
NCT05772104 RECRUITING
Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder
Sichuan Jishengtang Pharmaceutical Co., Ltd. n=495
NCT06074250 RECRUITING
Perinatal Depression & Anxiety (PDA) and Maternal Gut Microbiome
The Canadian College of Naturopathic Medicine n=100
NCT05970510 RECRUITING
A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.
Luye Pharma Group Ltd. n=555
NCT06243640 RECRUITING
Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD
Beijing Union Pharmaceutical Factory Ltd n=504
NCT06243614 RECRUITING
Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD
Beijing Union Pharmaceutical Factory Ltd n=410
NCT05510752 NOT YET RECRUITING
Cognitive Behavioural Therapy Versus Psychoeducation for Perinatal Anxiety
St. Joseph's Healthcare Hamilton n=216
NCT02568878 RECRUITING
Creatine for Depressed Male and Female Methamphetamine Users
Montana State University n=29
NCT05011396 TERMINATED
PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2
VistaGen Therapeutics, Inc. n=228
NCT06510504 COMPLETED
Efficacy of BNC210 in Acute, As-needed Treatment of Anxiety in Social Anxiety Disorder - 1
Bionomics Limited n=370
NCT05030350 TERMINATED
Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)
VistaGen Therapeutics, Inc. n=481
NCT05729373 COMPLETED
A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. n=434
NCT02819141 COMPLETED
Self-management of Sedative Therapy by Ventilated Patients
Mayo Clinic n=161
NCT04754802 COMPLETED
PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge
VistaGen Therapeutics, Inc. n=224
NCT06854601 COMPLETED
Safety and Efficacy of Mexidol® for ADHD in Children Aged 6-12
Pharmasoft n=333
NCT07092189 COMPLETED
Colposcopy Anxiety and the Role of Pre-procedure Nursing Intervention
Université de Sherbrooke n=140
NCT02349412 COMPLETED
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Alliance for Clinical Trials in Oncology n=405
NCT06103188 COMPLETED
Comparing the Effect of Melatonin, Diazepam, and Placebo on Decreasing the Level of Anxiety Preoperatively
University of Jordan n=87
NCT03277586 TERMINATED
Effects of Probiotics on Symptoms of Depression
Dr. Roumen Milev n=28
NCT05126459 COMPLETED
A Comparison of Oral Sedation-related Events of Three Multiagent Oral Sedation Regimens in Pediatric Dental Patients
Loma Linda University n=60
NCT02415309 COMPLETED
Premedication With Melatonin in Lumbar Medial Branch Block Procedure
United States Naval Medical Center, San Diego n=25
NCT03829241 COMPLETED
Randomized Trial of Adult Participants With Generalized Anxiety Disorder
Biohaven Pharmaceuticals, Inc. n=881
NCT03810456 COMPLETED
Transdiagnostic Cognitive Behavioral Treatment for Anxiety
VA Office of Research and Development n=359
NCT05586789 COMPLETED
A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders
Valenta Pharm JSC n=220
NCT03485274 COMPLETED
Substance Misuse To Psychiatric Disorders for Cannabis
The University of Hong Kong n=37
NCT03227562 TERMINATED
Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety?
Marion Trousselard n=120
NCT02386319 COMPLETED
Anxiolytic and Analgesic Effects of Melatonin
Herlev Hospital n=36
NCT03017508 COMPLETED
Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder
Yale University n=22
NCT04569760 WITHDRAWN
Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study
McMaster University
NCT04091139 COMPLETED
Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong
Chinese University of Hong Kong n=27
NCT04237532 COMPLETED
Sublingual Versus Intranasal Administration of Dexmedetomidine for Sedation of Children Undergoing Dental Treatment
Nourhan M.Aly n=42
NCT04393818 COMPLETED
Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19
Fundació d'investigació Sanitària de les Illes Balears n=560
NCT02686333 COMPLETED
Meditation for Depression and Anxiety Symptoms in Dialysis Patients
Lady Davis Institute n=50
NCT03069677 COMPLETED
Music vs Midazolam During Preop Nerve Block Placement
University of Pennsylvania n=160
NCT02305797 COMPLETED
EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD)
Edgemont Pharmaceuticals, LLC n=495
NCT02374567 TERMINATED
Pharmacovigilance in Gerontopsychiatric Patients
Hannover Medical School n=407

Data: ClinicalTrials.gov